Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RAS Mutations or Amplifications”

3 trials

Showing 3 of 3 results

Early research (Phase 1)Looking for participantsNCT07142980
What this trial is testing

A Phase I Study of HRS-7172 in Participants With Advanced Solid Tumors Harboring RAS Mutations or Amplifications

Who this might be right for
Advanced Solid Tumors Harboring RAS Mutations or Amplifications
Jiangsu HengRui Medicine Co., Ltd. 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07736612
What this trial is testing

A Pan-RAS Inhibitor in Combination With Anti-Tumor Therapy in Participants With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic CancerRAS Mutations or Amplifications
Zhejiang University 80
Early research (Phase 1)Looking for participantsNCT07189949
What this trial is testing

HRS-2329 in Participants With Advanced Solid Tumors Harboring RAS Mutations or Amplifications

Who this might be right for
Advanced Solid Tumors Harboring RAS Mutations or Amplifications
Jiangsu HengRui Medicine Co., Ltd. 120

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation